ATACAND Drug Patent Profile
✉ Email this page to a colleague
When do Atacand patents expire, and what generic alternatives are available?
Atacand is a drug marketed by Ani Pharms and is included in two NDAs.
The generic ingredient in ATACAND is candesartan cilexetil; hydrochlorothiazide. There are twenty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the candesartan cilexetil; hydrochlorothiazide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Atacand
A generic version of ATACAND was approved as candesartan cilexetil; hydrochlorothiazide by MYLAN on December 4th, 2012.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ATACAND?
- What are the global sales for ATACAND?
- What is Average Wholesale Price for ATACAND?
Summary for ATACAND
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 134 |
Clinical Trials: | 46 |
Patent Applications: | 3,907 |
Drug Prices: | Drug price information for ATACAND |
What excipients (inactive ingredients) are in ATACAND? | ATACAND excipients list |
DailyMed Link: | ATACAND at DailyMed |
Recent Clinical Trials for ATACAND
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
The University of Texas Health Science Center, Houston | Early Phase 1 |
AgoneX Biopharmaceuticals, Inc. | Phase 2 |
BioHealthonomics Inc. | Phase 2 |
Pharmacology for ATACAND
Drug Class | Angiotensin 2 Receptor Blocker |
Mechanism of Action | Angiotensin 2 Receptor Antagonists |
Paragraph IV (Patent) Challenges for ATACAND
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
ATACAND | Tablets | candesartan cilexetil | 4 mg, 8 mg, 16 mg and 32 mg | 020838 | 1 | 2006-12-22 |
US Patents and Regulatory Information for ATACAND
Expired US Patents for ATACAND
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ani Pharms | ATACAND | candesartan cilexetil | TABLET;ORAL | 020838-003 | Jun 4, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Ani Pharms | ATACAND | candesartan cilexetil | TABLET;ORAL | 020838-003 | Jun 4, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Ani Pharms | ATACAND | candesartan cilexetil | TABLET;ORAL | 020838-002 | Jun 4, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Ani Pharms | ATACAND | candesartan cilexetil | TABLET;ORAL | 020838-001 | Jun 4, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Ani Pharms | ATACAND | candesartan cilexetil | TABLET;ORAL | 020838-004 | Jun 4, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Ani Pharms | ATACAND | candesartan cilexetil | TABLET;ORAL | 020838-001 | Jun 4, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Ani Pharms | ATACAND | candesartan cilexetil | TABLET;ORAL | 020838-001 | Jun 4, 1998 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ATACAND
See the table below for patents covering ATACAND around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Norway | 924417 | ⤷ Sign Up | |
Hungary | 211608 | ⤷ Sign Up | |
Portugal | 97451 | PROCESSO PARA A PREPARACAO DE DERIVADOS DE BENZIMIDAZOLE E DE COMPOSICOES FARMACEUTICAS QUE OS CONTEM | ⤷ Sign Up |
Finland | 20012172 | ⤷ Sign Up | |
China | 1147515 | ⤷ Sign Up | |
Japan | 2682353 | ⤷ Sign Up | |
Austria | 157248 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ATACAND
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0459136 | SPC/GB97/018 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: CANDESARTAN CILEXETIL OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF.; REGISTERED: UK PL0017/0383 19970429; UK PL0017/0384 19970429; UK PL0017/0385 19970429; UK PL0017/0391 19970429; UK PL15561/0003 19970429; UK PL15661/0001 19970429; UK PL15661/0002 19970429; UK PL15661/0004 19970429 |
0459136 | SZ 8/1998 | Austria | ⤷ Sign Up | |
0459136 | 98C0016 | Belgium | ⤷ Sign Up | PRODUCT NAME: CANDESARTAN CILEXETIL; NAT. REGISTRATION NO/DATE: 212 IS 236 F3 19980119; FIRST REGISTRATION: GB PL 15661/0001 19970429 |
0459136 | 8/1998 | Austria | ⤷ Sign Up | PRODUCT NAME: CANDESARTAN CILEXETIL ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; NAT. REGISTRATION NO/DATE: 1-22232, 1-22233, 1-22235, 1-22236 19971119; FIRST REGISTRATION: GB PL 15661/0001 - PL 15661/0004 19970429 |
0459136 | 19875004 | Germany | ⤷ Sign Up | PRODUCT NAME: WIRKSTOFF DES ARZNEIMITTELS BLOPRESS BZW. DES ARZNEIMITTELS ATACAND IN ALLEN DEM SCHUTZ DES GRUNDPATENTS UNTERLIEGENDEN FORMEN; NAT. REGISTRATION NO/DATE: 41261.00.00 41261.01.00 41261.02.00 41261.03.00 41294.00.00 41294.01.00 41294.02.00 41294.03.00 19971203 FIRST REGISTRATION: GROSSBRITANNIEN 15661/0001 15661/0002 15661/0003 15661/0004 19970429 |
0459136 | C970044 | Netherlands | ⤷ Sign Up | PRODUCT NAME: CANDESARTAN, DESGENST IN DE VORM VAN EEN FARMACEUTISCH AAN- VAARDBAAR ZOUT OF VAN DE 1-(CYCLOHEXYLOXYCARBONYLOXY) ETHYLESTE R, IN HET BIJZONDER CILEXETILI CANDESARTANAS, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; NAT. REGISTRATION NO/DATE: RVG 21703 - RVG 21706 19971013; FIRST REGISTRATION: GB PL 15661/0001 - PL 15661/0004 19970429 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |